CIK: 1360376 - Address: C/o Onyx Pharmaceuticals, Inc., 249 E. Grand Ave., South San Francisco, CA 94080
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11254-3-24-5-19-7
P%wins10010050050050
S%ret1112-2-22-1451
S%wins83925045555063

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/2/13 18:54
7/1/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpM.d72428.5502537832D
7/2/13 18:54
7/1/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS.d-3,365132.630-25-4432D
5/16/13 20:39
5/14/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-40496.600-4-1232D
4/3/13 19:52
4/1/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-22886.140-3-736D
10/5/12 19:32
10/5/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-53190.000-6-1632D
7/27/12 20:25
7/25/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-39673.970-5-1049D
7/5/12 18:03
7/2/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpM.d40028.550143554D
1/5/12 18:34
1/3/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-5342.6433-1-334D4415213513123-20-3-2
9/2/11 18:20
9/1/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-3434.1433-1-335D529-9-20-546-31-1-54017
8/1/11 20:38
8/1/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-5533.2725-2-436D-827-4-12-6-8-2-3-3-943029
5/23/11 20:04
5/20/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-2643.0233-1-237D8988451628155-2-4-1-16-29-11
5/10/11 16:51
5/6/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS-15140.0033-4-938D6060381318199901-9-35-6
4/4/11 20:25
4/1/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOEVP,CorpS.d-5235.0221-1-342D211432-7-9-5-311094-12
5/24/10 16:53
5/20/10
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS-1424.0633-1-414D-341-19-23-23-20-11-7-4-22113290
4/2/10 18:53
4/1/10
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS.d-2230.1027-1-514D-5602-1-3-7-3-1-1-3-33-1317
8/14/09 18:51
8/14/09
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS-9830.7333-3-269D-4-25-52010-13-16-2-3015-9-4-12
7/24/09 13:50
7/22/09
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS-31835.9833-9-4212D36-793539303229-2-1-15-31-18-41
6/29/09 18:46
6/26/09
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS-8826.2717-3-1421D1-23-17-8911810-2-325111-24
5/21/09 16:48
5/20/09
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenCAOSVP,CorpS-3423.7528-1-625D-27-36-19-26-16-12-12-10-301332262
6/15/06 13:33
6/14/06
NPSPNps Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenUTOSVP BusiP504.745111102050-16-213-9
5/11/06 13:24
5/10/06
NPSPNps Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagLasowski JuergenUTOSVP BusiP505.20710New105810-26-13-28

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact